613609.1.1 | Lebanon | 13 | | Pathogenic | | Daher et al, 2011; Mahfouz et al, 2012 | Group of 13 healthy volunteers. Percent ... |
613609.1.2 | Lebanon | 15 | | Pathogenic | | Daher et al, 2011; Mahfouz et al, 2012 | Group of 15 healthy volunteers. No signi... |
613609.1.3 | Lebanon | 4 | | Pathogenic | | Daher et al, 2011; Mahfouz et al, 2012 | Group of 2 healthy volunteers. No signif... |
613609.2.1 | Libya | 17 | | Pathogenic | | Elmrghni et al. 2011 | Group of 17 individuals |
613609.4.1 | Algeria | 17 | | Pathogenic | | Roth et al. 1997 | Group of 17 healthy individuals |
114550.G.1.1 | Morocco | 34 | 20.8% | Pathogenic | Hepatocellular Carcinoma | Ezzikouri et al. 2008 | Group of 34 patients |
114550.G.1.2 | Morocco | 6 | 20.8% | Pathogenic | Hepatocellular Carcinoma | Ezzikouri et al. 2008 | Group of 3 patients |
114550.G.1.3 | Morocco | 60 | 14.4% | Pathogenic | | Ezzikouri et al. 2008 | Group of 60 healthy controls |
114550.G.1.4 | Morocco | 4 | 14.4% | Pathogenic | | Ezzikouri et al. 2008 | Group of 2 healthy controls |
613609.G.1.1 | Saudi Arabia | 129 | 0.177 | Pathogenic | | Alsmadi et al. 2006 | Group of 129 individuals. Blood samples ... |
613609.G.1.2 | Saudi Arabia | 62 | 0.177 | Pathogenic | | Alsmadi et al. 2006 | Group of 31 individuals. Blood samples w... |
613609.G.2.1 | Morocco | 6 | 13.2%±3.6% | Pathogenic | | Aguilar-Martinez et al. 2001 | Group of 3 newborns with Moroccan and Al... |
613609.G.2.2 | Morocco | 78 | 13.2%±3.6% | Pathogenic | | Aguilar-Martinez et al. 2001 | Group of 39 newborns with Moroccan and A... |
613609.G.4.1 | Tunisia | 26 | 25.8% | Pathogenic | | Sassi et al. 2004 | 13 homozygous individuals out of 570 hea... |
613609.G.4.2 | Tunisia | 147 | 25.8% | Pathogenic | | Sassi et al. 2004 | 147 heterozygous individuals out of 570 ... |
613609.G.5.1 | Egypt | 8 | | Pathogenic | | Settin et al. 2006 | 8 heterozygous individuals out of 48 cas... |
613609.G.5.2 | Egypt | 15 | | Pathogenic | | Settin et al. 2006 | 15 heterozygous individuals out of 70 he... |